Mechanisms of Enhancer Action

Abstract

Genomic studies have revealed a large number of distantly acting regulatory DNA regions (enhancers) activating transcription both in bacteria and in eukaryotes. Enhancers contain multiple specific binding sites for activator proteins that can locally disturb chromatin structure after binding to DNA and activate transcription initiated from enhancer targets (promoters) localised at variable distances from the enhancer. Typically, interactions between enhancer‐ and promoter‐bound proteins involve chromatin looping of intervening stretches of DNA organised in chromatin. These dynamic regulatory chromatin loops of different size and stability operate both in bacteria and in higher organisms where they form extensive and complex three‐dimensional networks that largely define gene expression patterns and identity of eukaryotic cells. Misalignment of these networks results in development of numerous human diseases including cancer.

Key Concepts

  • Enhancers are regulatory DNA sequences that regulate transcription both in bacteria and in higher organisms.
  • Enhancers are activated after binding of activator proteins to their specific binding sites localised within the enhancers.
  • Enhancers activate their targets (promoters) over variable distances.
  • An enhancer can work on multiple promoters and a promoter can be activated by multiple enhancers.
  • As a result, there is a dynamic regulatory network formed by regulatory chromatin loops of different size and stability.
  • Promoter activation involves interaction between proteins bound at the enhancers and promoters.
  • Enhancer–promoter interaction is accompanied by looping of intervening chromatin.
  • Gene activation involves a conformational change in promoter‐bound proteins or their covalent modification.

Keywords: distant regulation; enhancer; promoter; active chromatin; enhancer‐binding proteins; DNA looping; enhancer–promoter communication; transcription; poised chromatin

Figure 1. Mechanism of action of bacterial σ54‐dependent and eukaryotic enhancers. (a) Bacterial enhancers. Before transcriptional activation, bacterial enhancer‐binding proteins (bEBPs) are bound to the enhancer and do not communicate with the promoter containing bound, but inactive RNA polymerase forming a closed complex. After induction, phosphorylated bEBP oligomerises and can interact with the inactive RNA polymerase. Enhancer–promoter communication leads to looping of the intervening DNA and ATP hydrolysis‐dependent formation of the open, functionally active initiation complex at the promoter. After formation of the active initiation complex, the DNA loop is opened. (b) Eukaryotic enhancers. During differentiation, inactive enhancers are primed with pioneering transcription factors and marked by histone variants H2A.Z and H3.3. Early during development many promoters that become active later in development are pre‐marked by the histone modification and are poised. During enhancer activation, a set of specific transcription factors binds to the enhancer, attracting histone modifying enzymes such as histone acetyltransferases and inducing enhancer–promoter communication, chromatin looping and promoter activation. Histone modifications activating and inactivating enhancers are shown in green and red, respectively.
close

References

Adams CC and Workman JL (1995) Binding of disparate transcriptional activators to nucleosomal DNA is inherently cooperative. Molecular and Cellular Biology 15: 1405–1421.

Andrey G, Schopflin R, Jerkovic I, et al. (2017) Characterization of hundreds of regulatory landscapes in developing limbs reveals two regimes of chromatin folding. Genome Research 27: 223–233.

Beagan JA, Duong MT, Titus KR, et al. (2017) YY1 and CTCF orchestrate a 3D chromatin looping switch during early neural lineage commitment. Genome Research 27: 1139–1152.

Bradner JE, Hnisz D and Young RA (2017) Transcriptional addiction in cancer. Cell 168: 629–643.

Bush M and Dixon R (2012) The role of bacterial enhancer binding proteins as specialized activators of sigma54‐dependent transcription. Microbiology and Molecular Biology Reviews 76: 497–529.

Calo E and Wysocka J (2013) Modification of enhancer chromatin: what, how, and why? Molecular Cell 49: 825–837.

Cheng B, Li T, Rahl PB, et al. (2012) Functional association of Gdown1 with RNA polymerase II poised on human genes. Molecular Cell 45: 38–50.

Czudnochowski N, Bosken CA and Geyer M (2012) Serine‐7 but not serine‐5 phosphorylation primes RNA polymerase II CTD for P‐TEFb recognition. Nature Communications 3: 842.

De Santa F, Barozzi I, Mietton F, et al. (2010) A large fraction of extragenic RNA pol II transcription sites overlap enhancers. PLoS Biology 8: e1000384.

Dixon JR, Selvaraj S, Yue F, et al. (2012) Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature 485: 376–380.

Drissen R, Palstra RJ, Gillemans N, et al. (2004) The active spatial organization of the beta‐globin locus requires the transcription factor EKLF. Genes and Development 18: 2485–2490.

Elderkin S, Bordes P, Jones S, et al. (2005) Molecular determinants for PspA‐mediated repression of the AAA transcriptional activator PspF. Journal of Bacteriology 187: 3238–3248.

Ghavi‐Helm Y, Klein FA, Pakozdi T, et al. (2014) Enhancer loops appear stable during development and are associated with paused polymerase. Nature 512: 96–100.

Gibcus JH and Dekker J (2013) The hierarchy of the 3D genome. Molecular Cell 49: 773–782.

He HH, Meyer CA, Shin H, et al. (2010) Nucleosome dynamics define transcriptional enhancers. Nature Genetics 42: 343–347.

Hsieh ML, Hinton DM and Waters CM (2018) VpsR and cyclic di‐GMP together drive transcription initiation to activate biofilm formation in Vibrio cholerae. Nucleic Acids Research 46: 8876–8887.

Huo YX, Zhang YT, Xiao Y, et al. (2009) IHF‐binding sites inhibit DNA loop formation and transcription initiation. Nucleic Acids Research 37: 3878–3886.

Ing‐Simmons E, Seitan VC, Faure AJ, et al. (2015) Spatial enhancer clustering and regulation of enhancer‐proximal genes by cohesin. Genome Research 25: 504–513.

Iwafuchi‐Doi M and Zaret KS (2014) Pioneer transcription factors in cell reprogramming. Genes and Development 28: 2679–2692.

Jin C, Zang C, Wei G, et al. (2009) H3.3/H2A.Z double variant‐containing nucleosomes mark ‘nucleosome‐free regions’ of active promoters and other regulatory regions. Nature Genetics 41: 941–945.

Kulaeva OI, Nizovtseva EV, Polikanov YS, et al. (2012a) Distant activation of transcription: mechanisms of enhancer action. Molecular and Cellular Biology 32: 4892–4897.

Kulaeva OI, Zheng G, Polikanov YS, et al. (2012b) Internucleosomal interactions mediated by histone tails allow distant communication in chromatin. The Journal of Biological Chemistry 287: 20248–20257.

Lai F, Orom UA, Cesaroni M, et al. (2013) Activating RNAs associate with Mediator to enhance chromatin architecture and transcription. Nature 494: 497–501.

Liu Y, Bondarenko V, Ninfa A and Studitsky VM (2001) DNA supercoiling allows enhancer action over a large distance. Proceedings of the National Academy of Sciences of the United States of America 98: 14883–14888.

Mito Y, Henikoff JG and Henikoff S (2007) Histone replacement marks the boundaries of cis‐regulatory domains. Science 315: 1408–1411.

Naughton C, Sproul D, Hamilton C and Gilbert N (2010) Analysis of active and inactive X chromosome architecture reveals the independent organization of 30 nm and large‐scale chromatin structures. Molecular Cell 40: 397–409.

Nizovtseva EV, Clauvelin N, Todolli S, et al. (2017) Nucleosome‐free DNA regions differentially affect distant communication in chromatin. Nucleic Acids Research. DOI: 10.1093/nar/gkw1240.

North AK, Klose KE, Stedman KM and Kustu S (1993) Prokaryotic enhancer‐binding proteins reflect eukaryote‐like modularity: the puzzle of nitrogen regulatory protein C. Journal of Bacteriology 175: 4267–4273.

Orom UA and Shiekhattar R (2013) Long noncoding RNAs usher in a new era in the biology of enhancers. Cell 154: 1190–1193.

Papai G, Tripathi MK, Ruhlmann C, et al. (2010) TFIIA and the transactivator Rap1 cooperate to commit TFIID for transcription initiation. Nature 465: 956–960.

Phillips‐Cremins JE, Sauria ME, Sanyal A, et al. (2013) Architectural protein subclasses shape 3D organization of genomes during lineage commitment. Cell 153: 1281–1295.

Polikanov YS, Bondarenko VA, Tchernaenko V, et al. (2007) Probability of the site juxtaposition determines the rate of protein‐mediated DNA looping. Biophysical Journal 93: 2726–2731.

Rada‐Iglesias A, Bajpai R, Swigut T, et al. (2011) A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470: 279–283.

Roelfsema JH, White SJ, Ariyurek Y, et al. (2005) Genetic heterogeneity in Rubinstein‐Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. American Journal of Human Genetics 76: 572–580.

Rubtsov MA, Polikanov YS, Bondarenko VA, et al. (2006) Chromatin structure can strongly facilitate enhancer action over a distance. Proceedings of the National Academy of Sciences of the United States of America 103: 17690–17695.

Sanyal A, Lajoie BR, Jain G and Dekker J (2012) The long‐range interaction landscape of gene promoters. Nature 489: 109–113.

Smith E and Shilatifard A (2014) Enhancer biology and enhanceropathies. Nature Structural and Molecular Biology 21: 210–219.

Spitz F and Furlong EE (2012) Transcription factors: from enhancer binding to developmental control. Nature Reviews. Genetics 13: 613–626.

Thurman RE, Rynes E, Humbert R, et al. (2012) The accessible chromatin landscape of the human genome. Nature 489: 75–82.

Tinker RL, Williams KP, Kassavetis GA and Geiduschek EP (1994) Transcriptional activation by a DNA‐tracking protein: structural consequences of enhancement at the T4 late promoter. Cell 77: 225–237.

Tsai PF, Dell'Orso S, Rodriguez J, et al. (2018) A Muscle‐specific enhancer RNA mediates cohesin recruitment and regulates transcription in trans. Molecular Cell 71: 129–141 e8.

Vakoc CR, Letting DL, Gheldof N, et al. (2005) Proximity among distant regulatory elements at the beta‐globin locus requires GATA‐1 and FOG‐1. Molecular Cell 17: 453–462.

Wang KC, Yang YW, Liu B, et al. (2011) A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature 472: 120–124.

Weake VM and Workman JL (2010) Inducible gene expression: diverse regulatory mechanisms. Nature Reviews. Genetics 11: 426–437.

Whyte WA, Orlando DA, Hnisz D, et al. (2013) Master transcription factors and mediator establish super‐enhancers at key cell identity genes. Cell 153: 307–319.

Wu SF, Zhang H and Cairns BR (2011) Genes for embryo development are packaged in blocks of multivalent chromatin in zebrafish sperm. Genome Research 21: 578–589.

Yeung J and Naef F (2018) Rhythms of the genome: circadian dynamics from chromatin topology, tissue‐specific gene expression, to behavior. Trends in Genetics 34: 915–926.

Zaret KS and Carroll JS (2011) Pioneer transcription factors: establishing competence for gene expression. Genes and Development 25: 2227–2241.

Zentner GE, Tesar PJ and Scacheri PC (2011) Epigenetic signatures distinguish multiple classes of enhancers with distinct cellular functions. Genome Research 21: 1273–1283.

Zhu X, Ling J, Zhang L, et al. (2007) A facilitated tracking and transcription mechanism of long‐range enhancer function. Nucleic Acids Research 35: 5532–5544.

Further Reading

Bondarenko VA, Liu YV, Jiang YI and Studitsky VM (2002) Communication over a large distance: enhancers and insulators. Biochemistry and Cell Biology 81: 241–251.

Furlong EEM and Levine M (2018) Developmental enhancers and chromosome topology. Science 361: 1341–1345.

Hnisz D, Abraham BJ, Lee TI, et al. (2013) Super‐enhancers in the control of cell identity and disease. Cell 155: 934–947.

Heinz S, Romanoski CE, Benner C and Glass CK (2015) The selection and function of cell type‐specific enhancers. Nature Reviews. Molecular Cell Biology 16: 144–154.

Jones PA, Issa JP and Baylin S (2016) Targeting the cancer epigenome for therapy. Nature Reviews. Genetics 17: 630–641.

Lee TI and Young RA (2013) Transcriptional regulation and its misregulation in disease. Cell 152: 1237–1251.

Rowley MJ and Corces VG (2018) Organizational principles of 3D genome architecture. Nature Reviews. Genetics 19: 789–800.

Sengupta S and George RE (2017) Super‐enhancer‐driven transcriptional dependencies in cancer. Trends Cancer 3: 269–281.

Sur I and Taipale J (2016) The role of enhancers in cancer. Nature Reviews. Cancer 16: 483–493.

Vermunt MW, Zhang D and Blobel GA (2019) The interdependence of gene‐regulatory elements and the 3D genome. The Journal of Cell Biology 218: 12–26.

Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Nizovtseva, Ekaterina V, and Studitsky, Vasily M(Jun 2019) Mechanisms of Enhancer Action. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1002/9780470015902.a0028532]